Ruconest (Santarus, Inc.)
Welcome to the PulseAid listing for the Ruconest drug offered from Santarus, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Santarus, Inc. |
| NON-PROPRIETARY NAME: | c1 esterase inhibitor recombinant |
| SUBSTANCE NAME: | CONESTAT ALFA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-09-22 |
| END MARKETING DATE: | 0000-00-00 |
Ruconest HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ruconest from Santarus, Inc. |
| LABELER NAME: | Santarus, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2100(U/1) |
| START MARKETING DATE: | 2014-09-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68012-350_3c153275-2fb0-4620-89a5-846d3a70ad96 |
| PRODUCT NDC: | 68012-350 |
| APPLICATION NUMBER: | BLA125495 |
Other CONESTAT ALFA Pharmaceutical Manufacturers / Labelers:
